School of Nursing, Duke University, Durham, North Carolina, USA.
Center for Applied Genomics & Precision Medicine, School of Medicine, Duke University, Durham, North Carolina, USA.
J Am Med Inform Assoc. 2020 May 1;27(5):667-676. doi: 10.1093/jamia/ocaa007.
The purpose of this study was to examine the use of multiple mobile health technologies to generate and transmit data from diverse patients with type 2 diabetes mellitus (T2DM) in between clinic visits. We examined the data to identify patterns that describe characteristics of patients for clinical insights.
We enrolled 60 adults with T2DM from a US healthcare system to participate in a 6-month longitudinal feasibility trial. Patient weight, physical activity, and blood glucose were self-monitored via devices provided at baseline. Patients also responded to biweekly medication adherence text message surveys. Data were aggregated in near real-time. Measures of feasibility assessing total engagement in device submissions and survey completion over the 6 months of observation were calculated.
It was feasible for participants from different socioeconomic, educational, and racial backgrounds to use and track relevant diabetes-related data from multiple mobile health devices for at least 6 months. Both the transmission and engagement of the data revealed notable patterns and varied by patient characteristics.
Using multiple mobile health tools allowed us to derive clinical insights from diverse patients with diabetes. The ubiquitous adoption of smartphones across racial, educational, and socioeconomic populations and the integration of data from mobile health devices into electronic health records present an opportunity to develop new models of care delivery for patients with T2DM that may promote equity as well.
本研究旨在考察使用多种移动医疗技术在患者就诊之间生成和传输来自不同 2 型糖尿病(T2DM)患者的数据,以识别描述患者特征的模式,从而为临床提供见解。
我们招募了来自美国医疗系统的 60 名 T2DM 成年患者参加一项为期 6 个月的纵向可行性试验。患者在基线时通过提供的设备自行监测体重、身体活动和血糖,还需每隔两周回复药物依从性短信调查。数据近实时汇总。通过计算 6 个月观察期间设备提交和调查完成的总参与度来评估可行性措施。
来自不同社会经济、教育和种族背景的参与者至少使用和跟踪来自多种移动医疗设备的相关糖尿病数据 6 个月是可行的。数据的传输和参与情况揭示了显著的模式,且因患者特征而异。
使用多种移动医疗工具使我们能够从不同的糖尿病患者中得出临床见解。智能手机在不同种族、教育和社会经济人群中的普遍采用,以及将移动医疗设备的数据整合到电子健康记录中,为 T2DM 患者提供新的护理模式提供了机会,这可能也有助于实现公平。